Variant report
Variant | nsv983707 |
---|---|
Chromosome Location | chr13:38456859-38460148 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562842970 | chr13:38456864-38456865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531803084 | chr13:38456890-38456891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548388852 | chr13:38456927-38456928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78700296 | chr13:38456928-38456929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142474749 | chr13:38456942-38456943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368544575 | chr13:38456967-38456968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566503409 | chr13:38456997-38456998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144715823 | chr13:38457056-38457057 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147824694 | chr13:38457057-38457058 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79199919 | chr13:38457092-38457093 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568882114 | chr13:38457155-38457156 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537908602 | chr13:38457193-38457194 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554841537 | chr13:38457215-38457216 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373972063 | chr13:38457266-38457267 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10600412 | chr13:38457317-38457318 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143277267 | chr13:38457335-38457336 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78567045 | chr13:38457336-38457337 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201395172 | chr13:38457337-38457338 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534120026 | chr13:38457338-38457339 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572359606 | chr13:38457341-38457342 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs3028113 | chr13:38457342-38457343 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532184833 | chr13:38457343-38457344 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370317668 | chr13:38457360-38457361 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548367140 | chr13:38457403-38457404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112857916 | chr13:38457502-38457503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553789474 | chr13:38457526-38457527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577018666 | chr13:38457559-38457560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140253876 | chr13:38457645-38457646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2323638 | chr13:38457666-38457667 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs576494612 | chr13:38457680-38457681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77827222 | chr13:38457682-38457683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs150380375 | chr13:38457696-38457697 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1077026 | chr13:38457720-38457721 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs12875351 | chr13:38457782-38457783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1077025 | chr13:38457786-38457787 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542474118 | chr13:38457823-38457824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138071506 | chr13:38457827-38457828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs207473693 | chr13:38457834-38457835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533649656 | chr13:38457842-38457843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551903439 | chr13:38457860-38457861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113541636 | chr13:38457905-38457906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569404171 | chr13:38457942-38457943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551229565 | chr13:38457959-38457960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372076320 | chr13:38457989-38457990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74049239 | chr13:38458013-38458014 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs551885484 | chr13:38458065-38458066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs77389049 | chr13:38458069-38458070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568119436 | chr13:38458095-38458096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7329061 | chr13:38458104-38458105 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs373757347 | chr13:38458109-38458110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:38444800-38462200 | Weak transcription | Pancreas | Pancrea |
2 | chr13:38452800-38458000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr13:38453200-38458400 | Weak transcription | Osteobl | bone |
4 | chr13:38456600-38457000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr13:38457000-38457200 | Enhancers | HSMMtube | muscle |
6 | chr13:38457000-38457400 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr13:38457400-38457800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr13:38457800-38458200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr13:38457800-38458600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr13:38458000-38458400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr13:38458200-38458800 | Enhancers | HSMMtube | muscle |
12 | chr13:38458200-38459000 | Enhancers | NH-A | brain |
13 | chr13:38458200-38459200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr13:38458400-38458600 | Flanking Active TSS | Osteobl | bone |
15 | chr13:38458400-38458800 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr13:38458600-38458800 | Enhancers | Osteobl | bone |
17 | chr13:38458600-38459200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr13:38458800-38459000 | Flanking Active TSS | Osteobl | bone |
19 | chr13:38458800-38459400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
20 | chr13:38459000-38459200 | Enhancers | Osteobl | bone |
21 | chr13:38459200-38459400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
22 | chr13:38459200-38463000 | Weak transcription | Osteobl | bone |
23 | chr13:38459400-38463400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
24 | chr13:38460000-38461400 | Enhancers | Duodenum Mucosa | Duodenum |